Hangzhou Tigermed Consulting Co. Ltd (HNGZY)
Company Info
Highlights
$6.16B
$0.15
26.67
$6.50B
$2.04B
$615.19M
$4.00 - $4.30
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Hangzhou Tigermed Consulting Co. Ltd (HNGZY) returned 0.00% year-to-date (YTD) and -2.92% over the past 12 months.
HNGZY
0.00%
0.00%
-3.38%
-2.92%
N/A
N/A
N/A
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of HNGZY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||||
| 2024 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.94% | 0.00% | 0.00% | -1.43% | 0.00% | 0.00% | -3.38% | -2.92% |
| 2023 | 0.00% | 0.00% | 0.00% | 0.00% | -31.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -46.01% | -63.11% |
| 2022 | 0.00% | -9.80% | 0.00% | 0.00% | 0.00% | 0.00% | -9.80% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HNGZY is 21, meaning it’s performing worse than 79% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Hangzhou Tigermed Consulting Co. Ltd (HNGZY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Hangzhou Tigermed Consulting Co. Ltd provided a 1.99% dividend yield over the last twelve months, with an annual payout of $0.08 per share.
| Period | TTM | 2024 | 2023 |
|---|---|---|---|
| Dividend | $0.08 | $0.08 | $0.08 |
Dividend yield | 1.99% | 1.99% | 1.87% |
Monthly Dividends
The table displays the monthly dividend distributions for Hangzhou Tigermed Consulting Co. Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 |
| 2023 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 |
Dividend Yield & Payout
Dividend Yield
Hangzhou Tigermed Consulting Co. Ltd has a dividend yield of 1.99%, which is quite average when compared to the overall market.
Payout Ratio
Hangzhou Tigermed Consulting Co. Ltd has a payout ratio of 149.12%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hangzhou Tigermed Consulting Co. Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hangzhou Tigermed Consulting Co. Ltd was 67.69%, occurring on Dec 24, 2024. The portfolio has not yet recovered.
The current Hangzhou Tigermed Consulting Co. Ltd drawdown is 67.69%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -67.69% | Aug 1, 2022 | 605 | Dec 24, 2024 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hangzhou Tigermed Consulting Co. Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Hangzhou Tigermed Consulting Co. Ltd, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Hangzhou Tigermed Consulting Co. Ltd is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for HNGZY, comparing it with other companies in the Diagnostics & Research industry. Currently, HNGZY has a P/E ratio of 26.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HNGZY relative to other companies in the Diagnostics & Research industry. Currently, HNGZY has a P/S ratio of 0.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HNGZY in comparison with other companies in the Diagnostics & Research industry. Currently, HNGZY has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |